Sign up now

Sally Adams to Join Scancell as Development Director

Dr Sally Adams

News

Sally Adams to Join Scancell as Development Director

09 May, 2014

Published over 12 years ago. See the latest and most current information on News.

Scancell Holdings Plc

1 min read

Request information

Richard Goodfellow, Joint CEO of Scancell, said: “Sally has already worked closely with the Scancell team for several years. She has played a key role in the planning and execution of our successful clinical trial of SCIB1 in patients with metastatic melanoma and we are delighted that Sally will be joining our Board at such a pivotal juncture in the Company’s history. With her industry, scientific and drug development knowledge, Sally will continue to play an important role in the development of our ImmunoBody® and Moditope® platforms.”

Latest News

Magnetoelectric stem cell microrobots show promise for spinal cord injury repair

Research news

Magnetoelectric stem cell microrobots show prom...

Researchers in Zurich have developed biohybrid microrobots that combine neural progenitor cells w...

KQ Labs opens applications for ninth data-driven health cohort

News

KQ Labs opens applications for ninth data-drive...

Applications have opened for the ninth cohort of KQ Labs, a health tech accelerator supporting ea...

Two distinct weather patterns linked to higher risk of headache in migraine study

Research news

Two distinct weather patterns linked to higher...

Researchers have identified weather systems associated with increased headache onset in people wi...

Hidden parasitic disease may increase HIV and cervical cancer risk

Research news

Hidden parasitic disease may increase HIV and c...

Millions of women and girls should be tested for female genital schistosomiasis (FGS), according...

Live gut bacteria platform set to widen access to microbiome therapy for C. diff

Research news

Live gut bacteria platform set to widen access...

Mount Sinai researchers have developed a scalable manufacturing platform for live biotherapeutic...

Five-mRNA therapy reduces damage to heart after myocardial infarction in mice

Research news

Five-mRNA therapy reduces damage to heart after...

Researchers at The University of Osaka have reported that simultaneous delivery of five therapeut...

Protein quantum sensors could enable radio waves to control cells

Research news

Protein quantum sensors could enable radio wave...

Researchers have demonstrated that light-sensitive proteins can function as quantum sensors and r...

Chemotherapy may trigger immune changes that drive cancer resistance

Research news

Chemotherapy may trigger immune changes that dr...

Researchers at Houston Methodist have identified a mechanism through which a widely used chemothe...

Cytokine-armoured CAR T therapy shows promise against aggressive glioblastoma

Research news

Cytokine-armoured CAR T therapy shows promise a...

UCLA researchers have developed an engineered CAR T cell therapy that released immune-stimulating...

Related Stories

News

Scancell awarded Technology Grant

Scancell awarded Technology Grant

Laboratory products

DNA ImmunoBody® Patent Granted in first market

DNA ImmunoBody® Patent Granted in fi...

News

KQ Labs opens applications for ninth data-driven health cohort

KQ Labs opens applications for ninth...

News

POLL: What remains the biggest barrier to better productivity in your laboratory?

POLL: What remains the biggest barrie...

ILM 51.5 July 2026

Explore our Digital Edition

Discover the latest news and research

Digital edition

View all digital editions

Explore Our Other Sites

Envirotech Online

WATCH: What is the most important aspect of CEMS monitoring?

Pollution Solutions Online

AtkinsRéalis appoints Ian Dyck as global water market lead to drive growth in water infrastructure sector

Petro Online

Reliable jet fuel testing for today’s aviation challenges

Chromatography Today

Affordable liquid chromatography solvent delivery pump